Oncopeptides AB (publ) (STO:ONCO)
1.640
-0.051 (-3.02%)
Nov 20, 2026, 5:29 PM CET
Oncopeptides AB Revenue
Oncopeptides AB had revenue of 28.45M SEK in the quarter ending September 30, 2026, with 40.75% growth. This brings the company's total for the last twelve months to 103.50M, up 65.69% year-over-year. In the year 2025, Oncopeptides AB had annual revenue of 71.12M with 124.72% growth. That makes Oncopeptides AB the 37,365th largest company in the world by revenue and 507th in Sweden.
Revenue (ttm)
103.50M
Revenue Growth
+65.69%
P/S Ratio
6.26
Revenue / Employee
1.46M
Employees
71
Market Cap
648.27M
Revenue by Geography
- Germany 30.82M 43.3%
- Italy 17.06M 24.0%
- Spain 12.75M 17.9%
- Greece 8.56M 12.0%
- Austria 1.57M 2.2%
- Other Countries 352.00K 0.5%
Fiscal year ended Dec 31, 2025 See the full Oncopeptides AB breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 71.12M | 39.47M | 124.72% |
| Dec 31, 2024 | 31.65M | -3.57M | -10.14% |
| Dec 31, 2023 | 35.22M | 26.87M | 321.54% |
| Dec 31, 2022 | 8.36M | -109.94M | -92.94% |
| Dec 31, 2021 | 118.30M | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Cantargia AB | 317.31M |
| Sprint Bioscience AB | 134.13M |
| Corline Biomedical AB | 13.44M |
| Medivir AB | 8.51M |
| Xspray Pharma AB | 7.19M |
| Flerie AB | 2.60M |
| FluoGuide | 404.33K |
| Infant Bacterial Therapeutics AB | -1.00K |
Oncopeptides AB News
- 17 days ago - Oncopeptides AB Earnings Call Transcript: Q3 2026 - Transcripts
- 17 days ago - Oncopeptides AB Quarterly report: Q3 2026 - Filings
- 17 days ago - Oncopeptides AB Slides: Q3 2026 - Filings
- 5 weeks ago - Oncopeptides AB Transcript: Study update - Transcripts
- 5 weeks ago - Oncopeptides AB Press release: Study update - Filings
- 5 weeks ago - Oncopeptides AB Slides: Study update - Filings
- 2 months ago - Oncopeptides AB Earnings Call Transcript: Q2 2026 - Transcripts
- 2 months ago - Oncopeptides AB Quarterly report: Q2 2026 - Filings